Daniel Yerace's most recent trade in Coeptis Therapeutics Holdings Inc was a trade of 5,000 Non-Qualified Stock Options (right to buy) done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coeptis Therapeutics Holdi... | Daniel Yerace | Director, VP of Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 5,000 | 25,000 | - | - | Non-Qualified Stock Options (right to buy) | |
| Coeptis Therapeutics Holdi... | Daniel Yerace | Director, VP of Operations | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 05 Jan 2024 | 10,850 | 1,071,455 | - | 0.7 | 7,487 | Common Stock |
| Coeptis Therapeutics Holdi... | Daniel Yerace | Director, VP of Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 200,000 | 200,000 | - | - | Incentive Stock Options (right to buy) |